Under construction – not a live service
Sign in
Not yet taking people in EgyptNo phase

Heart ultrasound measure to predict complications after heart attack treatment

Studies whether an ultrasound heart measure predicts shock in heart attack patients.

Plain-language title generated from the registry record
Registry title: Prognostic Value of the LVOT VTI in STEMI Patients Undergoing PPCI

Key facts

Where
Asyut, EgyptSee the site

Where in Egypt

  • Assiut UniversityAsyut, EgyptNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Assiut University
Trial code
NCT07114978
Record updated
11 August 2025
Original description
* To determine whether LVOT VTI < 15 cm predicts the development of in-hospital cardiogenic shock or need for vasopressors in STEMI patients undergoing primary PCI. * To assess association of LVOT VTI with other adverse outcomes (in-hospital death, heart failure, arrhythmias, need for mechanical ventilation, prolonged hospital stay).Read full original descriptionShow less

Prognostic Value of the Left Ventricular Outflow Tract Velocity-time Integral in Predicting In-hospital Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention

* To determine whether LVOT VTI < 15 cm predicts the development of in-hospital cardiogenic shock or need for vasopressors in STEMI patients undergoing primary PCI. * To assess association of LVOT VTI with other adverse outcomes (in-hospital death, heart failure, arrhythmias, need for mechanical ventilation, prolonged hospital stay).

Inclusion: Adult patients (≥18 years), diagnosed with acute STEMI according to current ESC guidelines(3) and undergoing primary PCI within 24 hours of symptom onset; Patients undergo transthoracic echocardiography within 24 hours of admission.

Exclusion: Presence of significant aortic valve disease (e.g., severe aortic stenosis or regurgitation); LVOT obstruction or hypertrophic cardiomyopathy; Poor echocardiographic window; Refusal to participate.

ClinicalTrials.gov NCT07114978